Med Life (BSE:M) Earnings Yield %: 0.02% (As of Jul. 02, 2026)


BSE:M Med Life SA BSE:M
91 GF Score
Price lei13.22
GF Value lei7.84
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Med Life Earnings Yield %?

Med Life BSE:M +5.76% 91 Earnings Yield % is 0.02% as of Jul. 02, 2026. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.84 (Significantly Overvalued). The stock has 4 warning signs investors should review.

The earnings yield is an indication of how much return shareholders' investment in the company earned over the past 12 months. The higher the earnings yield is, the better.

As of today (2026-07-02), the stock price of Med Life is lei13.22. Med Life's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was lei0.00. Therefore, Med Life's earnings yield of today is 0.02%.

The earnings yield does not consider the growth of the business. A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Med Life's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 10.19%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Med Life  (BSE:M) Earnings Yield % Explanation

If the P/E ratio is an indication of how many years it takes for the company to earn back the stock price shareholders pay to buy the shares, the earnings yield is an indication of how much return shareholders' investment in the company earned over the past 12 months. The higher the earnings yield is, the better.

If a company loses money, the earnings yield is negative. This gives a more straightforward indication that the company is losing money. This is an advantage of using earnings yield instead of the P/E ratio in valuation. For valuation purposes, the P/B Ratio and the P/S Ratio should be used for companies that are losing money.

Like the P/E ratio, the earnings yield can be used to compare investments in different industries. It can even be used to compare the attractiveness of different asset classes such as bonds and cash. Of course, the earnings yield should not be the only factor in deciding which asset classes to invest.

Also similar to the P/E ratio, the earnings yield does not consider the growth of the business. A growing company with the same earnings yield should be more attractive than a company that has the same earnings yield but does not grow.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %.

Be Aware

Just like the P/E Ratio, non-recurring items such as selling part of the business, selling a previous investment, etc., can affect earnings yield dramatically. The earning yield is also a poor indication for cyclical companies. When a cyclical stock has a high earnings yield it is usually at the peak of its cycle.


Med Life Earnings Yield % Related Terms

BSE:M
91GF Score
Med Life SA BSE:M
Earnings Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life Earnings Yield % Calculation

Earnings yield is the reciprocal of the P/E Ratio.

Med Life's Earnings Yield for today is calculated as

Earnings Yield=Earnings per Share (Diluted) (TTM)/Share Price
=0.002/13.22
=0.02 %

Med Life's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was lei0.002 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Earnings Yield=Net Income /Market Cap

The earnings in the calculation is the Trailing Twelve Months earnings.

Frequently Asked Questions Learn more about Earnings Yield % →
What does a Earnings Yield % of 0.02% mean?
Med Life (BSE:M) has a Earnings Yield % of 0.02% as of Jul. 02, 2026. Earnings Yield equals per-share earnings divided by share price. It is the inverse of the price-earnings ratio. View historical data on Med Life and its competitors.
Is Med Life's Earnings Yield % too high?
Med Life's current Earnings Yield % is 0.02%. Overall, Med Life has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Earnings Yield % compare to HCA and THC?
Med Life's Earnings Yield % of 0.02% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield % for a Healthcare Providers & Services company?
A good Earnings Yield % depends on the Healthcare Providers & Services industry context. However, Earnings Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield % mean?
A high Earnings Yield % can signal that a stock is expensive relative to its fundamentals. Earnings Yield equals per-share earnings divided by share price. It is the inverse of the price-earnings ratio. View historical data on Med Life and its competitors. Med Life's current Earnings Yield % is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.84, compared to a current price of lei13.22 — trading 68.6% above its estimated fair value. The current Earnings Yield % is 0.02%. Med Life's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield % calculated?
Earnings Yield % is calculated from a company's financial statements. For Med Life (BSE:M), the current Earnings Yield % is 0.02% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (BSE:M) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei13.22 is trading 68.6% above its estimated GF Value™ of lei7.84. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for BSE:M:

  • Earnings Yield %: 0.02%
  • GF Value™: lei7.84 vs. price of lei13.22 (68.6% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Med Life Business Description

Other Exchanges 0RO5:UKO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score

Get the complete analysis for BSE:M

Earnings Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei13.22
Price
lei7.84
GF Value